Danimer Scientific (DNMR) is set to be delisted by the New York Stock Exchange for failing to meet the requirement that listed companies maintain an average global market capitalization of at least $15 million, the exchange said late Monday.
Trading in the company's class A stock has been suspended as delisting proceedings commence, the NYSE said.
"The company has a right to a review of this determination by a committee of the board of directors of the exchange," the NYSE said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。